Concourse Financial Group Securities, Inc. Aspira Women'S Health Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share
Q1 2023 May 15, 2023	BUY	$0.32 - $0.58 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.3 - $0.41 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.38 - $1.07 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.4 - $1.09 $0 - $0
Q1 2022 May 09, 2022	BUY	$0.88 - $1.81 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$1.63 - $3.43 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$3.19 - $5.48 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$4.78 - $6.84 $0 - $0
Q1 2021 May 13, 2021	BUY	$5.9 - $9.13 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$3.0 - $6.71 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$2.54 - $4.56 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$0.78 - $5.25 $0 - $0

Others Institutions Holding AWH

# of Institutions

Shares Held

431K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

417K
Shares

$412,951
0.21% of portfolio
American Portfolios Advisors Holbrook, NY

13.6K
Shares

$13,456
0.0% of portfolio

View Full List

About Aspira Women's Health Inc.

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

More about AWH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account